What Is Mounjaro?
Mounjaro (tirzepatide) is a prescription medication approved by Health Canada in 2022 for type 2 diabetes. However, due to its remarkable weight loss benefits, it is increasingly being prescribed off-label for weight management.
How Does Mounjaro Work for Weight Loss?
Mounjaro activates two key hormones that regulate appetite, digestion, and metabolism:
- Glucagon-Like Peptide-1 (GLP-1): Reduces hunger, slows digestion, and improves insulin secretion.
- Glucose-Dependent Insulinotropic Polypeptide (GIP): Enhances fat metabolism and supports long-term weight loss.
This dual-agonist approach makes Mounjaro more effective than single-hormone treatments like Ozempic (semaglutide), leading to greater appetite control and fat reduction.
How Effective Is Mounjaro for Weight Loss in Men?
Clinical trials show significant weight loss with Mounjaro:
- SURPASS Trials (Diabetes Patients): Weight loss between 9.5% and 12.5%.
- SURMOUNT-5 Trial (Non-Diabetic Patients): 20.2% weight loss, outperforming Wegovy’s 13.7%.
These results highlight Mounjaro as one of the most potent weight-loss treatments available, making it a promising option for men struggling with obesity or excess weight.
Is Mounjaro an Option for Weight Loss in Canada?
While not yet officially approved for weight loss, many Canadian healthcare providers prescribe it off-label to individuals with obesity or metabolic concerns.
Key Considerations:
- Prescription Required – Only available through a licensed healthcare provider.
- Potential Side Effects – May include nausea, vomiting, and digestive discomfort.
- Medical Supervision Essential – Regular check-ins ensure safety and effectiveness.
If you’re considering Mounjaro for weight loss, Beyoung Health provides safe and professional access to prescription treatments. Our licensed healthcare providers will assess your needs and ensure a personalized, secure, and effective weight-loss plan.